• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Investigating the Immunopathogenic Mechanisms Underlying MOGAD.

作者信息

McCombe Jennifer A, Flanagan Eoin P, Chen John J, Zekeridou Anastasia, Lucchinetti Claudia F, Pittock Sean J

机构信息

Department of Neurology, Mayo Clinic, Rochester, MN, USA.

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.

出版信息

Ann Neurol. 2022 Feb;91(2):299-300. doi: 10.1002/ana.26279. Epub 2021 Dec 22.

DOI:10.1002/ana.26279
PMID:34862992
Abstract
摘要

相似文献

1
Investigating the Immunopathogenic Mechanisms Underlying MOGAD.探究视神经脊髓炎谱系障碍（MOGAD）潜在的免疫致病机制。
Ann Neurol. 2022 Feb;91(2):299-300. doi: 10.1002/ana.26279. Epub 2021 Dec 22.
2
Central vein sign and other radiographic features distinguishing myelin oligodendrocyte glycoprotein antibody disease from multiple sclerosis and aquaporin-4 antibody-positive neuromyelitis optica.中央静脉征及其他影像学特征鉴别髓鞘少突胶质细胞糖蛋白抗体病与多发性硬化和水通道蛋白 4 抗体阳性视神经脊髓炎。
Mult Scler. 2022 Jan;28(1):49-60. doi: 10.1177/13524585211007086. Epub 2021 Apr 19.
3
Frequency of New Silent MRI Lesions in Myelin Oligodendrocyte Glycoprotein Antibody Disease and Aquaporin-4 Antibody Neuromyelitis Optica Spectrum Disorder.髓鞘少突胶质细胞糖蛋白抗体病和水通道蛋白 4 抗体视神经脊髓炎谱系疾病中新的沉默 MRI 病变的频率。
JAMA Netw Open. 2021 Dec 1;4(12):e2137833. doi: 10.1001/jamanetworkopen.2021.37833.
4
Clinical and immunological differences between MOG associated disease and anti AQP4 antibody-positive neuromyelitis optica spectrum disorders: Blood-brain barrier breakdown and peripheral plasmablasts.MOG 相关性疾病与抗 AQP4 抗体阳性视神经脊髓炎谱系疾病的临床和免疫学差异：血脑屏障破坏和外周浆细胞。
Mult Scler Relat Disord. 2020 Jun;41:102005. doi: 10.1016/j.msard.2020.102005. Epub 2020 Feb 12.
5
Serum Neurofilament Light and GFAP Are Associated With Disease Severity in Inflammatory Disorders With Aquaporin-4 or Myelin Oligodendrocyte Glycoprotein Antibodies.血清神经丝轻链和 GFAP 与水通道蛋白 4 或髓鞘少突胶质细胞糖蛋白抗体阳性的炎症性疾病的严重程度相关。
Front Immunol. 2021 Mar 16;12:647618. doi: 10.3389/fimmu.2021.647618. eCollection 2021.
6
Neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease: current topics.视神经脊髓炎谱系疾病和髓鞘少突胶质细胞糖蛋白抗体相关疾病：当前热点。
Curr Opin Neurol. 2020 Jun;33(3):300-308. doi: 10.1097/WCO.0000000000000828.
7
Exposure to TNF inhibitors is rare at MOGAD presentation.在MOGAD发病时，接触肿瘤坏死因子抑制剂的情况很少见。
J Neurol Sci. 2022 Jan 15;432:120044. doi: 10.1016/j.jns.2021.120044. Epub 2021 Oct 27.
8
Dysphagia in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody disease as a surrogate of brain involvement?视神经脊髓炎谱系疾病和髓鞘少突胶质细胞糖蛋白抗体病中的吞咽困难是否是脑受累的替代标志物？
Eur J Neurol. 2021 May;28(5):1765-1770. doi: 10.1111/ene.14691. Epub 2021 Jan 12.
9
COVID-19 in Patients With Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody Disease in North America: From the COViMS Registry.北美视神经脊髓炎谱系疾病和髓鞘少突胶质细胞糖蛋白抗体疾病患者的 COVID-19：来自 COViMS 登记处。
Neurol Neuroimmunol Neuroinflamm. 2021 Aug 24;8(5). doi: 10.1212/NXI.0000000000001057. Print 2021 Sep.
10
Modified models to distinguish central nervous system demyelinating diseases with brain lesions.用于区分有脑部病变的中枢神经系统脱髓鞘疾病的改良模型。
Mult Scler Relat Disord. 2021 Jul;52:102965. doi: 10.1016/j.msard.2021.102965. Epub 2021 Apr 17.

引用本文的文献

1
Performance of the 2023 diagnostic criteria for MOGAD: real-world application in a Chinese multicenter cohort of pediatric and adult patients.2023年MOGAD诊断标准的性能：在中国儿科和成人患者多中心队列中的实际应用
BMC Med. 2025 Jan 23;23(1):40. doi: 10.1186/s12916-025-03875-9.
2
Complement Activation Profiles Predict Clinical Outcomes in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.补体激活谱可预测髓鞘少突胶质细胞糖蛋白抗体相关疾病的临床结局。
Neurol Neuroimmunol Neuroinflamm. 2025 Jan;12(1):e200340. doi: 10.1212/NXI.0000000000200340. Epub 2024 Dec 11.
3
A retrospective study of myelin oligodendrocyte glycoprotein antibody-associated disease from a clinical laboratory perspective.
从临床实验室角度对髓鞘少突胶质细胞糖蛋白抗体相关疾病的回顾性研究。
Front Neurol. 2023 Sep 12;14:1187824. doi: 10.3389/fneur.2023.1187824. eCollection 2023.
4
More Efficient Complement Activation by Anti-Aquaporin-4 Compared With Anti-Myelin Oligodendrocyte Glycoprotein Antibodies.与抗髓鞘少突胶质细胞糖蛋白抗体相比，抗水通道蛋白 4 抗体更有效地激活补体。
Neurol Neuroimmunol Neuroinflamm. 2022 Nov 22;10(1). doi: 10.1212/NXI.0000000000200059. Print 2023 Jan.
5
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management.髓鞘少突胶质细胞糖蛋白抗体相关疾病（MOGAD）：临床与MRI特征、诊断及管理综述
Front Neurol. 2022 Jun 17;13:885218. doi: 10.3389/fneur.2022.885218. eCollection 2022.
6
Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease.视神经脊髓炎谱系障碍和髓鞘少突胶质细胞糖蛋白相关疾病中的血清和脑脊液生物标志物
Front Neurol. 2022 Mar 23;13:866824. doi: 10.3389/fneur.2022.866824. eCollection 2022.